Clinical Study Results

Research Sponsor: AstraZeneca AB

Treatments Studied: Budesonide, glycopyrronium, and formoterol fumarate metered-dose inhalers

Study Purpose: This study was done to learn if inhalers with different propellants affected how much budesonide, glycopyrronium, and formoterol fumarate got into the blood of healthy male participants

Protocol Number: D5985C00001

Thank you!

Thank you for taking part in the clinical study for budesonide, glycopyrronium, and formoterol fumarate metered-dose inhalers, also called BGF MDIs. The BGF MDIs were delivered through 3 inhalers, each with a different propellant.

AstraZeneca AB sponsored this study and thinks it is important to share the results. An independent non-profit organization called CISCRP helped prepare this summary of the study results for you.

If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.